- Home
- ITRI vs AXSM Comparison
ITRI vs AXSM Comparison
Compare ITRI & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRI
- AXSM
- Stock Information
- Founded
- ITRI 1977
- AXSM 2012
- Country
- ITRI United States
- AXSM United States
- Employees
- ITRI N/A
- AXSM N/A
- Industry
- ITRI Electrical Products
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- ITRI Industrials
- AXSM Health Care
- Exchange
- ITRI Nasdaq
- AXSM Nasdaq
- Market Cap
- ITRI 6.2B
- AXSM 5.1B
- IPO Year
- ITRI 1993
- AXSM 2015
- Fundamental
- Price
- ITRI $125.48
- AXSM $104.80
- Analyst Decision
- ITRI Strong Buy
- AXSM Strong Buy
- Analyst Count
- ITRI 10
- AXSM 16
- Target Price
- ITRI $134.30
- AXSM $176.56
- AVG Volume (30 Days)
- ITRI 730.8K
- AXSM 653.2K
- Earning Date
- ITRI 07-31-2025
- AXSM 08-04-2025
- Dividend Yield
- ITRI N/A
- AXSM N/A
- EPS Growth
- ITRI 44.31
- AXSM N/A
- EPS
- ITRI 5.85
- AXSM N/A
- Revenue
- ITRI $2,442,238,000.00
- AXSM $495,033,000.00
- Revenue This Year
- ITRI $3.00
- AXSM $61.62
- Revenue Next Year
- ITRI $6.01
- AXSM $59.02
- P/E Ratio
- ITRI $21.44
- AXSM N/A
- Revenue Growth
- ITRI 3.90
- AXSM 69.83
- 52 Week Low
- ITRI $90.11
- AXSM $75.56
- 52 Week High
- ITRI $140.04
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- ITRI 40.57
- AXSM 49.53
- Support Level
- ITRI $122.83
- AXSM $101.11
- Resistance Level
- ITRI $127.15
- AXSM $109.88
- Average True Range (ATR)
- ITRI 3.92
- AXSM 4.29
- MACD
- ITRI -1.51
- AXSM 0.06
- Stochastic Oscillator
- ITRI 23.17
- AXSM 61.77
About ITRI Itron Inc.
Itron Inc provides solutions that measure, manage, and analyze energy and water use. It operates under the Itron brand and manages and reports under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sense that do not have communications capability embedded for use with broader Itron systems. The Networked Solutions segment includes a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution. The Outcome segment includes their value-added, enhanced software and services which manage, organize, analyze, and interpret data to improve decision-making and maximize operational profitability.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.